Influence of folic acid on plasma homocysteine levels & arterial endothelial function in patients with unstable angina

Indian Journal of Medical Research

Volumn 129, Issue 3, 2009, Pages 279-284

  Guo, Hangyuan ^a   Chi, Jufang ^a   Xing, Yangbo ^a   Wang, Ping ^a  

^a SHAOXING UNIVERSITY   (China)

Author keywords

Acute coronary syndrome; Endothelial function; Folic acid; Homocysteine; Unstable angina; Vitamin B12

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHOLESTEROL; CYANOCOBALAMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FOLIC ACID; HOMOCYSTEINE; NITRATE; VITAMIN B COMPLEX;

ADULT; ANGIOCARDIOGRAPHY; ARTERY ENDOTHELIUM; ARTICLE; B SCAN; BRACHIAL ARTERY; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANALYSIS; FOLIC ACID BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; UNSTABLE ANGINA PECTORIS; ACUTE CORONARY SYNDROME; AGED; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; MIDDLE AGED; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; VASCULAR ENDOTHELIUM; VASODILATATION;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGINA, UNSTABLE; ENDOTHELIUM, VASCULAR; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; RISK FACTORS; VASODILATION; VITAMIN B 12; VITAMIN B COMPLEX;

EID: 67649664127     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Carson NA, Neill DW. Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland. Arch Disease Child 1962; 37: 505-13.
2. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56: 111-28.
3. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease: The European concerted Action Project. JAMA 1997; 277: 1775-81.
4. Mudd SH, Levy HL, Skouby F. Disorders of transsulfuration. In: Scriver CR, Beaud, Sly WS, Valle D, editors. The metabolic basis of inherited disease. New York: McGraw-Hill; 1989. p. 693-734.
5. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149-55.
6. Chacko KA. Plasma homocysteine levels in patients with coronary heart disease. Indian Heart J 1998; 50: 295-9.
7. Guo H, Lee JD, Ueda T, Cheng J, Shan J, Wang J. Hyperhomocysteinaemia & folic acid supplementation in patients with high risk of coronary artery disease. Indian J Med Res 2004; 119: 33-7.
8. Guo H, Lee JD, Ueda T, Shan J, Wang J. Plasma homocysteine levels in patients with early coronary artery stenosis and high risk factors. Jpn Heart J 2003; 44: 865-71.
9. Guo H, Lee JD, Xing Y, Cheng J, Ueda T, Toyoda K, et al. Changes of homocysteine levels and arterial endothelial function in patients with high risk of coronary artery disease after 6-month folic acid supplementation. Acta Cardiol 2004; 59: 503-6.
10. Braunwald E, Jones RH, Mark DB, Brown L, Cheitlin MD, et al. Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. Circulation 1994; 90: 613-22.
11. Ubbink JB, Hayward Vermaak WJ, Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 1991; 565: 441-6.
12. Woo KS, Chook P, Lolin YI, Cheung AS, Chan LT, Sun YY, et al. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 1997; 96: 2542-4.
13. Virdis A, Ghiadoni L, Salvetti G, Versari D, Taddei S, Salvett A. Hyperhomocyst(e)inemia: is this a novel risk factor in hypertension? J Nephrol 2002; 15: 414-21.
14. Wilcken DE, Wilcken B. The natural history of vascular disease in homocystinuria and the effects of treatment. J Inherit Metab Dis 1997; 20: 295-300.
15. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992; 268: 877-81.
16. Finkelstein JD. The metabolism of homocysteine: pathways and regulation. Eur J Pediatr 1998; 157 (Suppl 2): 40-4.
17. Malinow MR, Duell PB, Hess DL, Anderson PH, Kruger WD, Phillipson BE, et al. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med 1998; 338: 1009-15.
18. Woo KS, Chook P, Chan LL, Cheung AS, Fung WH, Qiao M, et al. Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation. Am J Med 2002; 112: 535-9.
19. Willems FF, Aengevaeren WR, Boers GH, Blom HJ, Verheugt FW. Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease. J Am Coll Cardiol 2002; 40: 766-72.
20. O'Grady HL, Leahy A, McCormick PH, Fitzgerald P, Kelly CK, Bouchier-Hayes DJ. Oral folic acid improves endothelial dysfunction in cigarette smokers. J Surg Res 2002; 106: 342-5.
21. Gottsater A, Forsblad J, Mattiasson I, Lindgarde F. Decreasing plasma endothelin-1 and unchanged plasma neopterin during folate supplementation in hyperhomocysteinemia. Int Angiol 2002; 21: 158-64.
22. van Wersch JW, Janssens Y, Zandvoort JA. Folic acid, vitamin B(12), and homocysteine in smoking and non-smoking pregnant women. Eur J Obstet Gynecol Reprod Biol 2002; 103: 18-21.
23. Holven KB, Aukrust P, Holm T, Ose L, Nenseter MS. Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects. Arterioscler Thromb Vasc Biol 2002; 22: 699-703.
24. Mayer O, Filipovsky J, Hromadka M, Svobodova V, Racek J, Mayer O Jr. Treatment of hyperhomocysteinemia with folic acid: effects on homocysteine levels, coagulation status, and oxidative stress markers. J Cardiovasc Pharmacol 2002; 39: 851-7.
25. Evans RW, Shaten BJ, Hempel JD, Cutler JA, Kuller LM. MRFIT Research Group Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor intervention Trial. Arterioscler Thromb Vasc Biol 1997; 17: 1947-53.
26. Turgan N, Boydak B, Habif S, Apakkan S, Ozmen D, Mutaf I, et al. Plasma homocysteine levels in acute coronary syndromes. Jpn Heart J 1999; 40: 729-36.
27. Folsom AR, Nieto FJ, McGovern PG, Tsai MY, Malinow MR, Eckfeldt JH, et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1998; 98: 204-10.
28. Al-Obaidi MK, Stubbs PJ, Collinson P, Conroy R, Graham I, Noble MI. Elevated homocysteine levels are associated with increased ischemic myocardial injury in acute coronary syndromes. J Am Coll Cardiol 2000; 36: 1217-22.
29. Omland T, Samuelsson A, Hartford M, Herlitz J, Karlsson T, Christensen B, et al. Serum homocysteine concentration as an indicator of survival in patients with acute coronary syndromes. Arch Intern Med 2000; 160: 1834-40.
30. Stubbs PJ, Al-Obaidi MK, Conroy RM, Collinson PO, Gradham IM, Noble IM. Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromes. Circulation 2000; 102: 605-10.
31. Woo KS, Chook P, Chan LL, Cheung AS, Fung WH, Qiao M, et al. Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation. Am J Med 2002; 112: 535-9.
32. O'Grady HL, Leahy A, McCormick PH, Fitzgerald P, Kelly CK, Bouchier-Hayes DJ. Oral folic acid improves endothelial dysfunction in cigarette smokers. J Surg Res 2002; 106: 342-5.
33. Gottsater A, Forsblad J, Mattiasson I, Lindgarde F. Decreasing plasma endothelin-1 and unchanged plasma neopterin during folate supplementation in hyperhomocysteinemia. Int Angiol 2002; 21: 158-64.